-
Big Drug Cos. Are Slackers in Emerging Mkts.
Wednesday, March 17, 2010 - 2:43pm
The leading drug makers aren’t doing enough to gain market share in emerging markets, according to a report that was issued by IMS Health, a research company based in Norwalk, Conn., that tracks prescriptions and other data on drug sales. That’s according to an article in today’s New York Times....
Read More >> -
Helmerich & Payne (HP) To Be Added To S&P 500 Index
Monday, February 22, 2010 - 7:25pmStandard & Poor's announced on Monday that Helmerich & Payne, Inc. (NYSE: HP) would replace IMS Health, Inc. (NYSE: RX) in the S&P 500 index. Standard & Poor's is making the move because IMS Health is being purchased by affiliates of TPG Capital LP and the Canada Pension Plan...
Read More >>
